Our novel results suggest that HPV-positive HNSCC enlist fibroblasts and generate a tumor-permissive microenvironment via TLR9-mediated engagement of PD-1/PD-L1/PD-L2 pathways. The gene discussed is PDCD1LG2; the disease is neoplasm.